GR3031505T3 - Use of intravenously administered iron in the therapy of tumoral and infectious diseases - Google Patents

Use of intravenously administered iron in the therapy of tumoral and infectious diseases

Info

Publication number
GR3031505T3
GR3031505T3 GR990402600T GR990402600T GR3031505T3 GR 3031505 T3 GR3031505 T3 GR 3031505T3 GR 990402600 T GR990402600 T GR 990402600T GR 990402600 T GR990402600 T GR 990402600T GR 3031505 T3 GR3031505 T3 GR 3031505T3
Authority
GR
Greece
Prior art keywords
tumoral
therapy
infectious diseases
intravenously administered
administered iron
Prior art date
Application number
GR990402600T
Other languages
English (en)
Inventor
Freiherr Von Nagell Helmut Rau
Original Assignee
Freiherr Von Nagell Helmut Rau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Freiherr Von Nagell Helmut Rau filed Critical Freiherr Von Nagell Helmut Rau
Publication of GR3031505T3 publication Critical patent/GR3031505T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR990402600T 1994-06-01 1999-10-13 Use of intravenously administered iron in the therapy of tumoral and infectious diseases GR3031505T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4419256A DE4419256A1 (de) 1994-06-01 1994-06-01 Verwendung von intravenös applizierbarem Eisen zur Therapie von Tumorerkrankungen und/oder Infektionskrankheiten
PCT/DE1995/000665 WO1995032711A1 (de) 1994-06-01 1995-05-17 Verwendung von intravenös applizierbarem eisen zur therapie von tumorerkrankungen und/oder infektionskrankheiten

Publications (1)

Publication Number Publication Date
GR3031505T3 true GR3031505T3 (en) 2000-01-31

Family

ID=6519591

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990402600T GR3031505T3 (en) 1994-06-01 1999-10-13 Use of intravenously administered iron in the therapy of tumoral and infectious diseases

Country Status (8)

Country Link
EP (1) EP0788355B1 (el)
AT (1) ATE184790T1 (el)
AU (1) AU2444695A (el)
DE (2) DE4419256A1 (el)
DK (1) DK0788355T3 (el)
ES (1) ES2137513T3 (el)
GR (1) GR3031505T3 (el)
WO (1) WO1995032711A1 (el)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19600744A1 (de) * 1996-01-11 1997-07-17 Werner Alois Prof Dipl Kaiser Magnetische Substanz zur lokalen hyperthermischen Behandlung vorwiegend kleiner Tumore

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2527158A1 (de) * 1975-06-18 1976-12-23 Herz Eberhard Arzneimittel zur behandlung von infektionskrankheiten und von nicht nachweisbar durch mikroorganismen ausgeloeste entzuendungen in der human- und veterinaermedizin
CH625125A5 (en) * 1975-09-26 1981-09-15 Biokema Sa Method for manufacturing a stable injectable solution of immunoglobulins and organic iron, and product obtained by this method
JPS6039681B2 (ja) * 1976-01-01 1985-09-07 日本臓器製薬株式会社 デキストリン・クエン酸・第二鉄多核複合体及び該複合体を含有する非経口用鉄剤
GB1546177A (en) * 1976-11-19 1979-05-16 Biokema Sa Process for the preparation of a stable injectable solution
GB2024007B (en) * 1978-06-30 1983-04-27 Gordon R T Cancer-treating composition containing inductively heatable particles
EP0227593A1 (en) * 1985-11-25 1987-07-01 The Hospital For Sick Children Use of chelating agents
GB8607137D0 (en) * 1986-03-21 1986-04-30 Efamol Ltd Compositions
JP2648329B2 (ja) * 1987-09-18 1997-08-27 エフ・ホフマン−ラ ロシュ アーゲー エイズの予防または治療用医薬組成物
DE3842143A1 (de) * 1988-12-15 1990-06-21 Nitsche Dietrich Verwendung von transferrin zur endotoxinneutralisation
WO1990007322A1 (en) * 1988-12-19 1990-07-12 David Gordon Diagnosis and treatment of viral effects
DE4117782C2 (de) * 1991-05-28 1997-07-17 Diagnostikforschung Inst Nanokristalline magnetische Eisenoxid-Partikel, Verfahren zu ihrer Herstellung sowie diagnostische und/oder therapeutische Mittel
FR2677885B1 (fr) * 1991-06-20 1994-08-26 Rocher Labo Biolog Vegetale Y Composition a base de plantes, utilisable en cosmetologie, en hygiene ou en pharmacie et son procede de preparation.
JP3100005B2 (ja) * 1992-07-28 2000-10-16 雪印乳業株式会社 ヒト免疫不全ウィルス感染・増殖抑制剤

Also Published As

Publication number Publication date
ES2137513T3 (es) 1999-12-16
DE4419256A1 (de) 1995-12-07
AU2444695A (en) 1995-12-21
DE59506911D1 (de) 1999-10-28
DK0788355T3 (da) 2000-03-20
EP0788355A1 (de) 1997-08-13
WO1995032711A1 (de) 1995-12-07
ATE184790T1 (de) 1999-10-15
EP0788355B1 (de) 1999-09-22

Similar Documents

Publication Publication Date Title
TW286283B (el)
TW250435B (el)
HK1030157A1 (en) Use of consensus interferon and compositions comprising consensus interferon.
HU9402914D0 (en) Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and an s-phase or m-phase specific antineoplastic agent
WO2001030802A3 (en) Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies
MY125984A (en) Pharmaceutical solutions of levosimendan.
PT1007055E (pt) Utilizacao de amifostina
GB9425730D0 (en) Compounds
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
MD990258A (en) Method of treatment of the acute viral hepatitis B
GB0020504D0 (en) Therapeutic method
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
NZ533309A (en) Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission
GR3031505T3 (en) Use of intravenously administered iron in the therapy of tumoral and infectious diseases
AU2229997A (en) Pharmaceutical compositions comprising natural human alpha-interferon
TR200000728T2 (tr) Kronik hepatit C' nin tedavisinde IFN-alfa ve amantadin kullanımı.
UA10219A (uk) Спосіб лікування туберкульозу легень
UA36043A (uk) Спосіб лікування фетоплацентарної недостатності
UA10259A (uk) Протинабряковий лікарський препарат "нейрополіосм"